Who is eligible for clinical trial NCT07024758?

Participants must meet the protocol's inclusion criteria for Obsessive Compulsive Disorder (OCD). The stated age range is 7 Years to 17 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT07024758 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-07-28

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD (NCT07024758)

🔵 Active, Not Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Baylor College of Medicine

🩺 Plain-English Summary (8th-Grade Level)

Anxiety disorders in children and adolescents are common and confer significant disability. Cognitive behavioral therapy (CBT) is the recommended treatment for youth with anxiety, yet many families cannot access CBT due to cost, practicalities of attending in-person treatment sessions, and a shortage of trained providers, especially in rural areas. To combat these barriers, other treatment methods have been developed. Previous research has shown that family-based, internet-delivered CBT (iCBT) for anxiety and OCD in youth has shown a significant reduction in anxiety symptoms. Parent-coached exposure therapy (PCET) focuses entirely on teaching parents and youth together how to address anxiety through the completion of in-session parent-coached exposures and assigning parent-coached exposure as homework in between sessions. Although both iCBT and PCET show positive results in treating pediatric anxiety in comparison to standard-care CBT, little is known about the comparative efficacy of iCBT and PCET. This research is being done to understand the comparative effectiveness of two different types of cognitive-behavioral therapy (CBT) for treating anxiety or OCD in youth.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (8 items) and avoid the listed exclusions (8 items).

Location: Baylor College of Medicine — Houston, Texas

Age range: 7 Years to 17 Years

🧪 Interventions in This Study

Parent Coached Exposure Therapy (BEHAVIORAL)
Family Based, Internet-Based Cognitive Behavioral Therapy (BEHAVIORAL)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

The child is between the ages of 7 to 17 years inclusive at enrollment.
The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS).
The child is appropriate for anxiety-focused treatment (e.g., anxiety or OCD is the primary or co-primary problem as diagnosed using the DIAMOND-KID).
One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration).
The participating parent/guardian lives with their child at least 50% of the time per self-report.
Both parent and child can read and understand English.
The participant has an IQ above 69, based on the KBIT-2, another valid test or clinician judgement (e.g., a previous assessment conducted, and report shared with study team).
Participants must be in the state of Texas for treatment sessions/assessments.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
The child has a diagnosis of a lifetime psychotic disorder and/or conduct disorder.
The child has significant, current and active suicidality/homicidality and/or self-injury requiring medical intervention.
The child has limited verbal communication abilities (e.g., no independent verbal communication).
The child is receiving concurrent psychotherapy with anxiety and/or OCD as the primary focus. They can pause ongoing therapy to enroll.
The child has initiated new antidepressant medication within 12-weeks of assessment (4-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.
The child has changed psychotropic medication dosage within 4-weeks of assessment (2-weeks for stimulants/benzodiazepines/antipsychotics) or during therapy.
The child requires a higher level of care than can be provided through the study (e.g., significant, current suicidal ideation).

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Baylor College of Medicine — Houston, Texas

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Obsessive Compulsive Disorder (OCD)

Brain-Oscillation Synchronized Stimulation of the DMPFC — Toronto, Ontario
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder — New York, New York
ERP to Improve Functioning in Veterans With OCD — East Orange, New Jersey
Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation — Houston, Texas
Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder — New Haven, Connecticut

Explore by condition: All Obsessive Compulsive Disorder (OCD) clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Review the official NIH record below to find the coordinating site.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗